© 1991 Oxford University Press
research-article |
Role of ras protooncogene activation in the formation of spontaneous and nitrosamine-induced lung tumors in the resistant C3H mouse
Laboratory of Molecular Toxicology, National Institute of Environmental Health Sciences Research Triangle Park, NC 27709, USA
1Present address: Inhalation Toxicology Research Institute, Lovelace Biochemical and Research Institute PO Box 5890, Albuquerque, NM 87l85, USA
The role of ras activation in the formation of spontaneous and chemically induced tumors was evaluated in the C3H mouse, a strain that has a low incidence of spontaneous lung tumors. Lung tumors were induced in C3H mice by treatment with 4-(N-methyl-N-nitrosainino)-1-(3-pyridyl)-1-butanone (NNK), 50 mg/kg, or nitrosodimethylamine (NDMA), 3 mg/kg for 7 weeks (3 times/week, i.p.). Eleven tumors from each treatment group were evaluated for activated ras genes by direct sequencing and oligonucleotide hybridization to slot blots of amplified DNA from these tumors. An activated K-ras gene was detected in 100% of NDMA- and NNK induced lung tumors, and the activating mutation detected in all samples was a GC to AT transition (GGT to GAT) in codon 12. In contrast, only 40% of the seven spontaneous lung tumors analyzed contained an activated K-ras gene and the mutations identified were not localized to either a specific base or codon. Both NNK and NDMA can be activated via t-hydroxylation to methylating agents. The GC to AT mutation observed in codon 12 in the nitrosamine-induced tumors is consistent with the formation of an O6-methyl-guanine (O6MG) adduct. Similar concentrations (13–15 pmoles/µmol deoxyguanosine) of this promutagenic adduct were detected in lungs during treatment with either NNK or NDMA. Thus, both these nitrosainines appear to activate the K-ras gene in lung through a direct genotoxic mechanism involving the formation of the O6MG adduct. The frequency of K-ras activation was similar in chemically induced lung tumors from the sensitive A/J strain and the C3H mouse, indicating that susceptibility for neoplasia in these strains is not related to the ability to activate this gene. Although tumors were induced in lung from 100% of C3H mice following chronic carcinogen exposure, both the size and the multiplicity was significantly less, while latency was longer than that observed in the A/J mouse. These differences could not be attributed to an altered propensity for DNA damage, but rather suggest that genetic loci which regulate clonal expansion and growth of initiated cells play a major role in the susceptibility of pulmonary neoplasia.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H.-H. L. Hong, C. D. Houle, T.-V. T. Ton, and R. C. Sills K-ras Mutations in Lung Tumors and Tumors from Other Organs are Consistent with a Common Mechanism of Ethylene Oxide Tumorigenesis in the B6C3F1 Mouse Toxicol Pathol, January 1, 2007; 35(1): 81 - 85. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Razani-Boroujerdi and M. L. Sopori Early Manifestations of NNK-Induced Lung Cancer: Role of Lung Immunity in Tumor Susceptibility Am. J. Respir. Cell Mol. Biol., January 1, 2007; 36(1): 13 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Houle, T.-V. T. Ton, N. Clayton, J. Huff, H.-H. L. Hong, and R. C. Sills Frequent p53 and H-ras Mutations in Benzene- and Ethylene Oxide-Induced Mammary Gland Carcinomas from B6C3F1 Mice Toxicol Pathol, October 1, 2006; 34(6): 752 - 762. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Jackson, I. Lea, A. Rashid, S. D. Peddada, and J. K. Dunnick Genetic Alterations in Cancer Knowledge System: Analysis of Gene Mutations in Mouse and Human Liver and Lung Tumors Toxicol. Sci., April 1, 2006; 90(2): 400 - 418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Lambertini, K. Surin, T.-V. T. Ton, N. Clayton, J. K. Dunnick, Y. Kim, H.-H. L. Hong, T. R. Devereux, and R. C. Sills Analysis of p53 Tumor Suppressor Gene, H-ras Protooncogene and Proliferating Cell Nuclear Antigen (PCNA) in Squamous Cell Carcinomas of HRA/Skh Mice Following Exposure to 8-Methoxypsoralen (8-MOP) and UVA Radiation (PUVA Therapy) Toxicol Pathol, February 1, 2005; 33(2): 292 - 299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.C. Sills, H.L. Hong, G. Flake, C. Moomaw, N. Clayton, G.A. Boorman, J. Dunnick, and T.R. Devereux o-Nitrotoluene-induced large intestinal tumors in B6C3F1 mice model human colon cancer in their molecular pathogenesis Carcinogenesis, April 1, 2004; 25(4): 605 - 612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-V. T. Ton, H.-H. L. Hong, C. H. Anna, J. K. Dunnick, T. R. Devereux, R. C. Sills, and Y. Kim Predominant K-ras Codon 12 G -> A Transition in Chemically Induced Lung Neoplasms in B6C3F1 Mice Toxicol Pathol, January 1, 2004; 32(1): 16 - 21. [Abstract] [PDF]
|
|
|
|
 |
|
 T. J. Koh, J. K. Field, A. Varro, T. Liloglou, P. Fielding, G. Cui, J. Houghton, G. J. Dockray, and T. C. Wang Glycine-Extended Gastrin Promotes the Growth of Lung Cancer Cancer Res., January 1, 2004; 64(1): 196 - 201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wang, Z. Zhang, E. Kastens, R. A. Lubet, and M. You Mice with Alterations in Both p53 and Ink4a/Arf Display a Striking Increase in Lung Tumor Multiplicity and Progression: Differential Chemopreventive Effect of Budesonide in Wild-type and Mutant A/J Mice Cancer Res., August 1, 2003; 63(15): 4389 - 4395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Peterson, N. M. Thomson, D. L. Crankshaw, E. E. Donaldson, and P. J. Kenney Interactions between Methylating and Pyridyloxobutylating Agents in A/J Mouse Lungs: Implications for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced Lung Tumorigenesis Cancer Res., August 1, 2001; 61(15): 5757 - 5763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-M. Hayashi, H.-H. L. Hong, K. Toyoda, T.-V. T. Ton, T. R. Devereux, R. R. Maronpot, J. Huff, and R. C. Sills High Frequency of Ras Mutations in Forestomach and Lung Tumors of B6C3F1 Mice Exposed to 1-Amino-2,4-dibromoanthraquinone for 2 Years Toxicol Pathol, June 1, 2001; 29(4): 422 - 429. [Abstract] [PDF]
|
|
|
|
|
|
H.-H. L. Hong, T. R. Devereux, R. L. Melnick, C. R. Moomaw, G. A. Boorman, and R. C. Sills Mutations of ras Protooncogenes and p53 Tumor Suppressor Gene in Cardiac Hemangiosarcomas from B6C3F1 Mice Exposed to 1,3-Butadiene for 2 Years Toxicol Pathol, July 1, 2000; 28(4): 529 - 534. [Abstract] [PDF]
|
|
|
|
|
|
D. Gulezian, D. Jacobson-Kram, C. B. Mccullough, H. Olson, L. Recio, D. Robinson, R. Storer, R. Tennant, J. M. Ward, and D. A. Neumann Review Article: Use of Transgenic Animals for Carcinogenicity Testing: Considerations and Implications for Risk Assessment Toxicol Pathol, May 1, 2000; 28(3): 482 - 499. [Abstract] [PDF]
|
|
|
|
|
|
J. Mimoto, K. Kiura, K. Matsuo, T. Yoshino, I. Takata, H. Ueoka, M. Kataoka, and M. Harada (-)-Epigallocatechin gallate can prevent cisplatin-induced lung tumorigenesis in A/J mice Carcinogenesis, May 1, 2000; 21(5): 915 - 919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.C. Sills, H.L. Hong, R.L. Melnick, G.A. Boorman, and T.R. Devereux High frequency of codon 61 K-ras A->T transversions in lung and Harderian gland neoplasms of B6C3F1 mice exposed to chloroprene (2-chloro-1,3-butadiene) for 2 years, and comparisons with the structurally related chemicals isoprene and 1,3-butadiene Carcinogenesis, April 1, 1999; 20(4): 657 - 662. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Liu, X. Qin, and S. L. Gerson Reduced lung tumorigenesis in human methylguanine DNA—methyltransferase transgenic mice achieved by expression of transgene within the target cell Carcinogenesis, February 1, 1999; 20(2): 279 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-H. L. Hong, T. R. Devereux, J. H. Roycroft, G. A. Boorman, and R. C. Sills Frequency of ras Mutations in Liver Neoplasms from B6C3FX Mice Exposed to Tetrafluoroethylene for Two Years Toxicol Pathol, September 1, 1998; 26(5): 646 - 650. [Abstract] [PDF]
|
|
|
|
|
|
L. S. Trukhanova, H.-H. L. Hong, R. C. Sills, A. D. Bowser, B. Gaul, G. A. Boorman, V. S. Turusov, T. R. Devereux, and D. Dixon Predominant p53 G->A Transition Mutation and Enhanced Cell Proliferation in Uterine Sarcomas of CBA Mice Treated with 1,2-Dimethylhydrazine Toxicol Pathol, May 1, 1998; 26(3): 367 - 374. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Penn and C. A. Snyder 1,3 Butadiene, a Vapor Phase Component of Environmental Tobacco Smoke, Accelerates Arteriosclerotic Plaque Development Circulation, February 1, 1996; 93(3): 552 - 557. [Abstract] [Full Text]
|
|